Concordia Healthcare (CXRX) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Concordia Healthcare Announces Third Quarter 2015 Results
November 12, 2015 5:00 PM EST- A transformational quarter with strong performance by legacy business -
Third Quarter 2015 Highlights
Concordia announced its acquisition of Amdipharm Mercury Limited ("AMCo") for $3.3 billion1. Adjusted EBITDA2 of $71.7 million, growing 254 per cent versus the same period in 2014. Adjusted EPS2 of $1.46, growing 157 per cent over the third quarter in 2014. Revenue growth of 161 per cent to $94.9 million compared to the third quarter of 2014.2015 Nine Month Highlights
Revenue growth of 163 per cent to $208.9 million compared to the same period in 2014.... More